Find information about GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) for health care professionals. Please see Important Safety Information on this website.

Review the dosing schedule for GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant), including information about the recommended regimen. Please see Important …

GARDASIL 9 is indicated in males 9 through 45 years of age for the prevention of anal, oropharyngeal and other head and neck cancers caused by HPV Types 16, 18, 31, 33, 45, 52, …

GARDASIL 9 is indicated in males 9 through 45 years of age for the prevention of anal, oropharyngeal and other head and neck cancers caused by HPV Types 16, 18, 31, 33, 45, 52, …

Efficacy and effectiveness of GARDASIL are relevant to GARDASIL 9 since the vaccines are manufactured similarly and contain 4 of the same HPV L1 VLPs. In men aged 27-45, …

GARDASIL 9 is indicated in males 9 through 45 years of age for the prevention of anal, oropharyngeal and other head and neck cancers caused by HPV Types 16, 18, 31, 33, 45, 52, …

Feb 28, 2024 · Review the storage and handling instructions for GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant). Please see Important Safety Information on …

Aug 16, 2024 · MerckVaccines is a site for health care professionals to find information about Merck's vaccine portfolio, as well as vaccine tools and resources.

Review reimbursement information for GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant), including CPT® Codes and ICD-10-CM® Codes. Please see Important Safety …

Enroll locations into Merck pricing programs and maintain account and location information associated with user accounts and organizations. Merck Access Program